Firebrick Pharma (FRE) Stock Overview

Firebrick Pharma Limited engages in the development and partnering of broad-spectrum antimicrobial spray for the treatment of common cold under the Nasodine name in Australia. The company was incorporated in 2012 and is based in Melbourne, Australia.

FRE Stock Information

Symbol

FRE

Address

440 Collins StreetMelbourne, VIC 3000Australia

Founded

Trading hours

10:00 AM - 4:00 PM AEST

Website

https://www.firebrickpharma.com

Country

🇦🇺 Australia

Phone Number

1300 301 874

Firebrick Pharma (FRE) Price Chart

Firebrick Pharma Overview: Key Details and Summary

Stock data	2023	Change
Price	$0.04411864521821761	N/A
Market Cap	$7.86M	N/A
Shares Outstanding	178.05M	52.80%
Employees	0	N/A
Shareholder Equity	2.48M	-70.09%

Valuation	2023	Change
P/S Ratio	13943.44	N/A
P/B Ratio	3.17	N/A

Growth	2023	Change
Return on Equity	-1.8646	N/A

Earnings	2023	Change
Revenue	$563.36	N/A
Earnings	-$4.62M	N/A
Gross Margin	1.00	N/A
Operating Margin	-8.27K	N/A
Net income margin	-8.20K	N/A

Financial Strength	2023	Change
Total Assets	$2.02M	N/A
Cash on Hand	$1.60M	N/A
Debt to Equity	0.1388	276.24%
Current Ratio	$5.11	-72.37%